Shepard M. Goldberg serves as Executive at Echo Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Shepard M. Goldberg has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Mar 21, 2017 involved receiving (via award) 25,000 shares valued at $0.
Shepard M. Goldberg currently holds 32,250 shares of Echo Therapeutics, Inc. (ECTE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Shepard M. Goldberg has been a net neutral trader of ECTE stock. They have purchased $0 and sold $0 worth of shares.
Shepard M. Goldberg's most recent insider trade was on Mar 21, 2017, when they sold 25,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |